Triple test

Triple test

The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects).

The term "multiple-marker screening test" is sometimes used instead.[1][2] This term can encompass the "double test" and "quadruple test" (described below).

The Triple test measures serum levels of AFP, estriol, and beta-hCG, with a 70% sensitivity and 5% false-positive rate. It is complemented in some regions of the United States, as the Quad test (adding inhibin A to the panel, resulting in an 81% sensitivity and 5% false-positive rate for detecting Down syndrome)[3] and other prenatal diagnosis techniques, although it remains widely used in Canada[4] and other countries. A positive test means having a high risk of chromosomal abnormalities (and neural tube defects), and such patients are then referred for more sensitive and specific procedures to receive a definitive diagnosis, mostly invasive procedures like amniocentesis. The Triple test can be understood as an early predecessor to a long line of subsequent technological improvements. In some American states, such as Missouri, Medicaid reimburses only for the Triple test and not other potentially more accurate screening tests, whereas California offers Quad tests to all pregnant women.[5]


Conditions screened

The most common abnormality the test can screen is trisomy 21 (Down syndrome). In addition to Down syndrome, the triple and quadruple tests screen for fetal trisomy 18 also known as Edward's syndrome, open neural tube defects, and may also detect an increased risk of Turner syndrome, triploidy, trisomy 16 mosaicism, fetal death, Smith-Lemli-Opitz syndrome, and steroid sulfatase deficiency.[6]

Values measured

The triple test measures the following three levels in the maternal serum:[7]


The levels may indicate increased risk for certain conditions:

AFP UE3 hCG Associated conditions
low low high Down Syndrome
low low low trisomy 18 (Edward's syndrome)
high n/a n/a neural tube defects like spina bifida associated with increase levels of acetylcholinesterase in aminonic fluid, or omphalocele, or gastroschisis, or multiple gestation like twins or triplets

An estimated risk is calculated and adjusted for the expectant mother's age;[8] if she's diabetic; if she's having twins or other multiples, and the gestational age of the fetus. Weight and ethnicity may also be used in adjustments.[citation needed] Many of these factors affect the levels of the substances being measured and the interpretation of the results.

The test is for screening, not for diagnosis,[9] and does not have nearly the same predictive power of amniocentesis or chorionic villus sampling. The screening test carries a much lower risk to the fetus, however, and in conjunction with the age-related risk of the patient it is useful to help determine the need for more invasive tests.

Triple Test Result

If only two of the hormones above are tested for, then the test is called a double test. A quad test tests an additional hormone, inhibin. Furthermore, the triple test may be combined with an ultrasound measurement of nuchal translucency.[citation needed]

3.0 Normal 3.1 Normal 3.5 Normal 4.0 Normal 4.7 Normal 5.0 Normal 5.1 Abnormal

Quadruple test

A test of levels of dimeric inhibin A (DIA) is sometimes added to the other three tests, under the name "quadruple test."[10] Other names used include "quad test", "quad screen", or "tetra screen." Inhibin A (DIA) will be found high in cases of Trisomy 21 and low in cases of Trisomy 18.

See also


  1. ^ Renier MA, Vereecken A, Van Herck E, Straetmans D, Ramaekers P, Buytaert P (March 1998). "Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome". Hum. Reprod. 13 (3): 744–8. doi:10.1093/humrep/13.3.744. PMID 9572446. 
  2. ^ Yudin MH, Prosen TL, Landers DV (October 2003). "Multiple-marker screening in human immunodeficiency virus-positive pregnant women: Screen positivity rates with the triple and quad screens". Am. J. Obstet. Gynecol. 189 (4): 973–6. doi:10.1067/S0002-9378(03)01053-6. PMID 14586337. 
  3. ^ Lao, M. R.; Calhoun, B. C.; Bracero, L. A.; Wang, Y.; Seybold, D. J.; Broce, M.; Hatjis, C. G. (2009). "The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population". Journal of Medical Screening 16 (2): 55–59. doi:10.1258/jms.2009.009017. PMID 19564516.  edit
  4. ^
  5. ^
  6. ^ Benn PA (2002). "Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing". Clin. Chim. Acta 323 (1–2): 1–16. doi:10.1016/S0009-8981(02)00186-9. PMID 12135803. 
  7. ^ Ball RH, Caughey AB, Malone FD, et al. (2007). "First- and second-trimester evaluation of risk for Down syndrome". Obstet Gynecol 110 (1): 10–7. doi:10.1097/01.AOG.0000263470.89007.e3. PMID 17601890. 
  8. ^ "Downs Syndrome Screening at Nottingham City Hospital". Retrieved 2007-12-20. 
  9. ^ Lamlertkittikul S, Chandeying V (2007). "Experience on triple markers serum screening for Down syndrome fetus in Hat Yai, Regional Hospital". J Med Assoc Thai 90 (10): 1970–6. PMID 18041410. 
  10. ^ Wald NJ, Morris JK, Ibison J, Wu T, George LM (2006). "Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers". Prenat. Diagn. 26 (6): 559–64. doi:10.1002/pd.1459. PMID 16700087. 

External links

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Triple-Test — Triple Test,   Blutuntersuchung bei Schwangeren in der 15./16. Schwangerschaftswoche zur Feststellung von kindlichen Fehlbildungen. Dabei werden drei Hormone (Alpha Fetoprotein, HCG und Östradiol) bestimmt und aus dem Verhältnis der Hormonwerte… …   Universal-Lexikon

  • triple test — n triple screen * * * (for evaluation of breast masses) the use of physical examination, mammography, and fine needle aspiration to evaluate palpable breast masses. Results of each method are given point values of 1 (benign), 2 (suspicious), or 3 …   Medical dictionary

  • Triple-Test — Der Triple Test (auch bezeichnet als MoM Test: MoM = Multiples of the Median, englisch: Das Vielfache der Median Konzentration) ist eine aufgrund der vergleichsweise unsicheren Ergebnisse, die er bringt, umstrittene Methode der Pränataldiagnostik …   Deutsch Wikipedia

  • Triple test — Le triple test est un test de dépistage pratiqué généralement entre 15 et 20 semaines de grossesse. Il inclut non seulement le dosage de l alpha fœtoprotéine sanguine, mais aussi celui de l HCG et de l estriol libre. En France, ce test est… …   Wikipédia en Français

  • triple test — 1) (in prenatal screening) a blood test that can be performed between the 15th and 20th weeks of pregnancy. Levels of alpha fetoprotein (AFP), unconjugated oestriol (uE3), and human chorionic gonadotrophin (hCG) in the serum are computed with… …   The new mediacal dictionary

  • triple screen — n a blood test for pregnant women for alpha fetoprotein, human chorionic gonadotropin, and estriol in order to assess the risk of fetal abnormality (as Down syndrome, anencephaly, and spina bifida) called also triple test …   Medical dictionary

  • Triple H — during his ring entrance. Ring name(s) Triple H Hunter Hearst Helmsley Jean Paul Lévesque Terra Ryzin Billed height …   Wikipedia

  • Triple-Play — ist in der Telekommunikation seit etwa 2005 ein Marketingbegriff für das gebündelte Anbieten der drei Dienste audiovisuelle Unterhaltung (Fernsehen, Video on Demand), (IP )Telefonie und Internet (siehe auch Konvergenz). Allgemein werden damit… …   Deutsch Wikipedia

  • Triple play — ist in der Telekommunikation seit etwa 2005 ein Marketingbegriff für das gebündelte Anbieten der drei Dienste audiovisuelle Unterhaltung (Fernsehen, Video on Demand), (IP )Telefonie und Internet (siehe auch Konvergenz). Allgemein werden damit… …   Deutsch Wikipedia

  • Triple Nine Society — Gründer Richard Canty, Ronald Hoeflin, Ronald Penner, Edgar Van Vleck und Kevin Langdon Gründung 1979 Personen …   Deutsch Wikipedia